218 related articles for article (PubMed ID: 30333819)
1. TACI Isoforms Regulate Ligand Binding and Receptor Function.
Garcia-Carmona Y; Ting AT; Radigan L; Athuluri Divakar SK; Chavez J; Meffre E; Cerutti A; Cunningham-Rundles C
Front Immunol; 2018; 9():2125. PubMed ID: 30333819
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of plasma cells by isoforms of human TACI.
Garcia-Carmona Y; Cols M; Ting AT; Radigan L; Yuk FJ; Zhang L; Cerutti A; Cunningham-Rundles C
Blood; 2015 Mar; 125(11):1749-58. PubMed ID: 25631768
[TBL] [Abstract][Full Text] [Related]
3. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
[TBL] [Abstract][Full Text] [Related]
4. Features of Isoforms of Human Soluble TACI.
Fichtner ML; Rübsamen H; Smolle M; Schaller J; Feederle R; Bültmann A; Kümpfel T; Schneider P; Thaler FS; Meinl E
J Immunol; 2023 Jul; 211(2):199-208. PubMed ID: 37272840
[TBL] [Abstract][Full Text] [Related]
5. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
6. TACI and endogenous APRIL in B cell maturation.
Garcia-Carmona Y; Fribourg M; Sowa A; Cerutti A; Cunningham-Rundles C
Clin Immunol; 2023 Aug; 253():109689. PubMed ID: 37422057
[TBL] [Abstract][Full Text] [Related]
7. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
8. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
9. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
10. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
Hoffmann FS; Kuhn PH; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister HW; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
J Immunol; 2015 Jan; 194(2):542-52. PubMed ID: 25505277
[TBL] [Abstract][Full Text] [Related]
11. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
12. TACI regulates IgA production by APRIL in collaboration with HSPG.
Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
[TBL] [Abstract][Full Text] [Related]
13. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
Banday VS; Thyagarajan R; Sundström M; Lejon K
Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
[TBL] [Abstract][Full Text] [Related]
15. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
[TBL] [Abstract][Full Text] [Related]
16. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
[TBL] [Abstract][Full Text] [Related]
17. APRIL is overexpressed in cancer: link with tumor progression.
Moreaux J; Veyrune JL; De Vos J; Klein B
BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
[TBL] [Abstract][Full Text] [Related]
18. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]